A phase I clinical trial of intrahepatic artery delivery of TG6002 in combination with oral 5-fluorocytosine in patients with liver-dominant metastatic colorectal cancer

Emma J. West, Alain Sadoun, Kaidre Bendjama, Philippe Erbs, Cristina Smolenschi, Philippe A. Cassier, Thierry de Baere, Sophie Sainte-Croix, Maud Brandely, Alan A. Melcher, Fay Ismail, Karen J. Scott, Angela Bennett, Emma Banks, Ewa Gasior, Sarah Kent, Marta Kurzawa, Christopher Hammond, Jai V. Patel, Fiona J. Collinson, Chris Twelves, D. Alan Anthoney, Dan Swinson, Adel Samson
doi: https://doi.org/10.1101/2024.07.30.24311046

Article usage

Article usage: July 2024 to November 2024

AbstractFullPdf
Jul 202414408
Aug 20242112148
Sep 2024110352
Oct 202449824
Nov 202427111
Back to top
Posted July 31, 2024.
Download PDF

Supplementary Material

Data/Code
Email
A phase I clinical trial of intrahepatic artery delivery of TG6002 in combination with oral 5-fluorocytosine in patients with liver-dominant metastatic colorectal cancer
Emma J. West, Alain Sadoun, Kaidre Bendjama, Philippe Erbs, Cristina Smolenschi, Philippe A. Cassier, Thierry de Baere, Sophie Sainte-Croix, Maud Brandely, Alan A. Melcher, Fay Ismail, Karen J. Scott, Angela Bennett, Emma Banks, Ewa Gasior, Sarah Kent, Marta Kurzawa, Christopher Hammond, Jai V. Patel, Fiona J. Collinson, Chris Twelves, D. Alan Anthoney, Dan Swinson, Adel Samson
medRxiv 2024.07.30.24311046; doi: https://doi.org/10.1101/2024.07.30.24311046
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area